Cargando…
SIRT2 as a potential new therapeutic target for Alzheimer’s disease
Alzheimer’s disease is the most common cause of dementia globally with an increasing incidence over the years, bringing a heavy burden to individuals and society due to the lack of an effective treatment. In this context, sirtuin 2, the sirtuin with the highest expression in the brain, has emerged a...
Autores principales: | Sola-Sevilla, Noemi, Puerta, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479864/ https://www.ncbi.nlm.nih.gov/pubmed/37488853 http://dx.doi.org/10.4103/1673-5374.375315 |
Ejemplares similares
-
Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence
por: Sola-Sevilla, Noemi, et al.
Publicado: (2021) -
Biomarkers in Alzheimer’s disease
por: Janeiro, Manuel H., et al.
Publicado: (2020) -
SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease
por: Sola-Sevilla, Noemi, et al.
Publicado: (2023) -
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
por: Gutiérrez, Irene L., et al.
Publicado: (2022) -
SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
por: Shen, Pan, et al.
Publicado: (2021)